Percutaneous transluminal renal angioplasty in nonatherosclerotic renovascular hypertension. Long-term results.
Nineteen stenotic arteries in 16 patients with severe renovascular hypertension of nonatherosclerotic nature (fibromuscular dysplasia in 13, neurofibromatosis in 3) were treated with percutaneous transluminal renal angioplasty. The procedure was technically successful in 12 of 14 (86%) stenoses in the fibromuscular dysplasia subgroup but in only one of five (20%) lesions in the neurofibromatosis subgroup. Hypertension was abated (3 patients) or disappeared (8 patients) in 11 of the 12 (92%) patients with fibromuscular dysplasia who had a technically successful angioplasty, an effect that was sustained at latest follow-up (avg, 37 mo; range, 10-73 mo). The only complication encountered was a retroperitoneal hematoma that resolved uneventfully. Coupled with those from other centers, the results of the present study indicate that angioplasty offers a strong potential for curability in patients with renovascular hypertension caused by fibromuscular dysplasia and that percutaneous transluminal renal angioplasty should be considered the treatment of choice for the initial management of all patients with fibromuscular renovascular hypertension.
Millan
V G
VG
McCauley
J
J
Kopelman
R I
RI
Madias
N E
NE
D000293:Adolescent; D000328:Adult; D000800:Angioplasty, Balloon; D001794:Blood Pressure; D002648:Child; D005260:Female; D005352:Fibromuscular Dysplasia / Q000503:physiopathology / Q000628:therapy; D005500:Follow-Up Studies; D006801:Humans; D006978:Hypertension, Renovascular / Q000628:therapy*; D007668:Kidney / Q000502:physiology; D007677:Kidney Function Tests; D008134:Long-Term Care; D008297:Male